MELBOURNE researchers are a step closer to growing transplantable tissue to patch up heart defects after turning human skin cells into “beating heart” tissue that can connect to the circulation system.
The major breakthrough by the O’Brien Institute in preclinical models could eventually aid heart-attack victims and is also tipped to reduce the number of animals used in testing new drugs.
O’Brien’s cardiac regeneration group leader, Dr Shiang Lim, said while laboratories around the world were making heart cells from stem cells, his team had advanced the research by successfully connecting the human heart tissue to the host’s blood circulation.
“People have managed to create 3D heart tissue in the laboratory, but the size and thickness is limited by the lack of blood vessels,” Dr Lim said.
“We’re letting the body do its natural work.
“The blood vessels aren’t just sitting there, they’re functional and supplying blood to the heart tissue.”
Researchers first genetically reprogrammed human skin cells to become stem cells, which they further changed into heart cells using chemical and electrical stimulation.
Using a 3D chamber pioneered by the Melbourne regenerative surgery institute, they implanted these human heart cells into an animal model, connecting it to its blood vessel.
The findings, published in the journal, Stem Cells Translational Medicine, showed that four weeks after implantation, the implanted human heart cells had survived, engrafted into the surrounding tissue and were beating.
Dr Lim said the first application for their beating heart tissue would be for drug testing to help reduce and complement animal experimentation, reducing the time and cost of getting a medication on to market.
“We know a lot of drugs discovered and tested in animals work great, but when it’s translated into humans doesn’t work because of the biological differences,” he said.
“We can test on this engineered human heart tissue first before moving into clinical trials.”
Go deeper with Bing News on:
- Critical Review: BioNTech (NASDAQ:BNTX) vs. Organovo (NASDAQ:ONVO)on February 19, 2020 at 12:56 am
Further, it involved in various programs to develop its NovoTissues transplantable tissues to address various serious unmet medical needs in adult and pediatric populations primarily focusing on liver ...
- Donor Profile, Tissue Evaluation and Comparison of Voluntary and Motivated Corneal Donation in Nepal Eye Bank.on February 18, 2020 at 11:30 am
76.2% of total tissues were of optical quality. Utilization rate of transplantable tissues was 97%. Tissues from motivated donors were significantly “younger” (p=0.0001), had better endothelial count ...
- Putting Together the Pieces: Tissue Engineering Research & 3D Printing Possibilitieson January 31, 2020 at 4:00 pm
Thus, new methodologies are required that can be easily incorporated into future transplantable medical devices capable of directing cell and tissue formation.” The logical next step would be to ...
- What Living To 150 Might Look Likeon January 30, 2020 at 10:18 am
Eat this food. Take this supplement. Make these lifestyle changes. Read this study. Count on your genes. It’s a never-ending buzz surrounding longevity, and we’re all in, waiting to hear the latest ...
- MTF Biologics Announces Partnership With Net Health Wound Care EMRon January 21, 2020 at 6:16 am
Our subsidiary, International Institute for the Advancement of Medicine (IIAM), provides non-transplantable organs and tissues to the medical research community for purposes of combatting and ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Engineered human heart tissue
- Novoheart Named 2020 Venture 50 Company, Ranked Among Year’s Top Performing Stocks in Life Scienceson February 20, 2020 at 6:30 am
Novoheart Among Top 10 TSX-V Performers in Clean Technology & Life Sciences SectorRanking based on share price increase, trading volume and ...
- Engineering light-controllable CAR T cells for cancer immunotherapyon February 19, 2020 at 12:47 pm
This on-target off-tumor toxicity is especially lethal when the infused CAR T cells are activated by the normal cells expressing low levels of target antigens in the heart, liver, or lung ... a ...
- A geometrically adaptable heart valve replacementon February 19, 2020 at 12:25 pm
2 Wyss Institute for Biologically Inspired Engineering ... in most children with congenital heart valve defects. Outcomes of valve replacement remain suboptimal, particularly in young children, ...
- A conductive cardiac patch for damaged heartson February 19, 2020 at 12:21 pm
Engineering a patch for application to constantly moving ... repeated stretching and to incorporate electroconductive properties that mimic those of human heart tissue. The new material can facilitate ...
- Regenerative Medicine Market 2025 : Japan Tissue Engineering Co., Ltd., Stryker Corporationon February 17, 2020 at 4:18 pm
Regenerative medicine is a part of translational research in the fields of molecular biology and tissue engineering. This type of medicine involves replacing and regenerating human cells, organs ...